Published on
February 4, 2023
- 01:13 GMT
TissueGen and University of Texas System Awarded $42 Million in Patent Infringement Verdict against Boston Scientific
The verdict was for patent infringement claims relating to Boston Scientific’s SYNERGY™ coronary stents sold by Boston Scientific Corporation. DALLAS, TX, USA, February 3, 2023 /EINPresswire.com/ -- On January 31, 2023, The Board of Regents of the …
Distribution channels:
Business & Economy, Healthcare & Pharmaceuticals Industry
...
